A research round up of 2016

2016 was an amazing year for MS research and progress is not slowing down. We look back at some of the key moments and take a sneak peek at what we can expect in 2017.

Research wins in 2016

A big moment for progressive MS

In September we announced the International Progressive MS Alliance would invest over £10 million in progressive MS research.

This money has gone to three research projects that are looking into treatments for progressive MS.

Clinical trial success

We saw some hugely promising clinical trial results in 2016. These include ocrelizumab for primary progressive and relapsing MS and siponimod for people with secondary progressive MS – to name just a couple.